A Prospective Cohort Study Comparing Metabolic Response Evaluation by F-18 FDG PET-CT Versus Conventional Imaging for Outcome Stratification in Patients With Advanced Breast Cancer Receiving First-line Systemic Therapy

Description:

This study is a prospective cohort study comparing metabolic response evaluation by F-18 FDG PET-CT versus conventional imaging for outcome stratification in patients with advanced breast cancer receiving first-line systemic therapy.

Sponsor:

Samsung Medical Center

Contacts:

Yeon Hee Park, phD

yeonh.park@samsung.com

+82-2-3410-1780

F-18 FDG

Isotope(s):
Target(s):
  • Glucose Transport
XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468